BR112017012852A2 - novo vírus de tilápia e usos do mesmo - Google Patents

novo vírus de tilápia e usos do mesmo

Info

Publication number
BR112017012852A2
BR112017012852A2 BR112017012852-7A BR112017012852A BR112017012852A2 BR 112017012852 A2 BR112017012852 A2 BR 112017012852A2 BR 112017012852 A BR112017012852 A BR 112017012852A BR 112017012852 A2 BR112017012852 A2 BR 112017012852A2
Authority
BR
Brazil
Prior art keywords
tilv
relates
nucleic acid
acid sequences
polypeptides
Prior art date
Application number
BR112017012852-7A
Other languages
English (en)
Inventor
Ian Lipkin W.
Briese Thomas
Mishra Nischay
Bacharach Eran
Eldar Avi
Original Assignee
The Trustees Of Columbia University In The City Of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Trustees Of Columbia University In The City Of New York filed Critical The Trustees Of Columbia University In The City Of New York
Publication of BR112017012852A2 publication Critical patent/BR112017012852A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/00034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/00034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

a invenção é direcionada ao vírus da tilápia do lago ou tilv e sequências de ácidos nucleicos isolados e seus polipeptídeos. a invenção também se refere a sondas e primers, e a anticorpos contra antígenos do tilv, e ao uso desses reagentes para detectar a presença ou ausência do tilv em um animal. a invenção também se refere a irnas que visam sequências de ácido nucleico do tilv. a invenção também se refere a composições imunogênicas, incluindo anticorpos e vacinas, para a indução de uma resposta imune contra o tilv em um animal. a invenção também se refere a construtos de genes e células que compreendem o tilv e sequências de ácidos nucleicos isolados e seus polipeptídeos para serem usados no desenvolvimento de agentes profiláticos e terapêuticos.
BR112017012852-7A 2014-12-15 2015-12-15 novo vírus de tilápia e usos do mesmo BR112017012852A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462091824P 2014-12-15 2014-12-15
US62/091,824 2014-12-15
PCT/US2015/065795 WO2016100328A1 (en) 2014-12-15 2015-12-15 Novel tilapia virus and uses thereof

Publications (1)

Publication Number Publication Date
BR112017012852A2 true BR112017012852A2 (pt) 2018-01-09

Family

ID=56127461

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017012852-7A BR112017012852A2 (pt) 2014-12-15 2015-12-15 novo vírus de tilápia e usos do mesmo

Country Status (12)

Country Link
US (4) US10183072B2 (pt)
CN (2) CN107427570A (pt)
BR (1) BR112017012852A2 (pt)
CO (1) CO2017007105A2 (pt)
CR (1) CR20210528A (pt)
EC (1) ECSP17045428A (pt)
HK (1) HK1244700A1 (pt)
IL (3) IL252919B (pt)
MX (2) MX371220B (pt)
MY (2) MY176597A (pt)
SG (3) SG11201704887SA (pt)
WO (1) WO2016100328A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL230970A0 (en) * 2014-02-13 2014-09-30 Univ Ramot Tilapia virus vaccines
MX2018008529A (es) * 2016-01-10 2019-06-06 Abic Biological Laboratories Ltd Virus de la tilapia de tipo ortomixo.
CN108018377B (zh) * 2017-12-07 2021-07-20 中国水产科学研究院珠江水产研究所 一种罗湖病毒的rt-lamp检测引物组、试剂盒及方法
CN108018378A (zh) * 2017-12-11 2018-05-11 中国水产科学研究院珠江水产研究所 一种罗湖病毒Taq-man探针荧光定量PCR检测试剂盒及检测方法
CN108192869A (zh) * 2018-01-24 2018-06-22 武汉轻工大学 一种斑点叉尾鮰头肾巨噬细胞原代分离培养方法及应用
CN108220483A (zh) * 2018-02-12 2018-06-29 深圳出入境检验检疫局动植物检验检疫技术中心 一种用于罗非鱼湖病毒检测的试剂、检测方法及应用
CN109234451B (zh) * 2018-09-26 2021-04-16 中国水产科学研究院长江水产研究所 一种罗非鱼细小病毒TiPV CPA检测引物及应用
CN109852588B (zh) * 2018-12-24 2023-03-07 中国水产科学研究院珠江水产研究所 一种抗罗非鱼免疫球蛋白IgM的单克隆抗体及其细胞株和应用
CN110616281A (zh) * 2019-10-29 2019-12-27 周伟光 一种应用实时荧光rt-pcr定量检测罗湖病毒的方法
CN111436390B (zh) * 2020-04-20 2021-11-16 中国热带农业科学院热带生物技术研究所 一种降低TiLV对罗非鱼致死率的温度调控养殖系统及方法
CN113122510A (zh) * 2021-04-12 2021-07-16 中国水产科学研究院黑龙江水产研究所 一种传染性造血器官坏死病疫苗及其病毒在胖头鱥肌肉细胞上扩增的方法
CN113755645B (zh) * 2021-09-30 2023-06-09 厦门海关技术中心 一种检测罗湖病毒的荧光定量rt-pcr引物对和探针，试剂盒和检测方法
CN113718061B (zh) * 2021-09-30 2023-06-09 厦门海关技术中心 一种同时检测罗湖病毒和病毒性神经坏死病毒的双重rt-pcr的引物组，试剂盒和方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737730B1 (fr) 1995-08-10 1997-09-05 Pasteur Merieux Serums Vacc Procede de purification de virus par chromatographie
MXPA04001660A (es) * 2001-08-27 2004-11-22 Advanced Bionutrition Corp Suministro para el control de enfermedad en acuacultura y agricultura usando alimentos nutritivos que contienen proteinas bioactivas producidas por virus.
AU2002233969A1 (en) 2001-12-07 2003-06-23 Schweitzer Chemical Corporation Usa Vaccines and antibodies produced from viruses derived from an immortal cell line of grouper epinephelus coioides
US8796436B2 (en) 2003-04-17 2014-08-05 Alnylam Pharmaceuticals, Inc. Modified iRNA agents
WO2008108660A2 (en) 2007-03-07 2008-09-12 Nofima Akvaforsk-Fiskeriforskning As Fish disease detection
US9366667B2 (en) 2009-10-02 2016-06-14 The Trustees Of Columbia University In The City Of New York Piscine reovirus diagnostic compositions
MX2015003825A (es) * 2012-09-26 2015-11-06 Fvg Ltd Subunidades de vacunas de inmersion para peces.
IL230970A0 (en) * 2014-02-13 2014-09-30 Univ Ramot Tilapia virus vaccines

Also Published As

Publication number Publication date
IL252919B (en) 2022-07-01
US10183072B2 (en) 2019-01-22
IL266234A (en) 2019-06-30
CR20210528A (es) 2021-12-06
US11583579B2 (en) 2023-02-21
CN107427570A (zh) 2017-12-01
MX2017007876A (es) 2018-11-09
US10973902B2 (en) 2021-04-13
US20170360918A1 (en) 2017-12-21
MX2021002525A (es) 2022-06-02
MY192642A (en) 2022-08-29
US20180369360A1 (en) 2018-12-27
US20200254084A1 (en) 2020-08-13
WO2016100328A8 (en) 2017-01-19
CO2017007105A2 (es) 2018-01-05
US10596249B2 (en) 2020-03-24
IL252919A0 (en) 2017-08-31
HK1244700A1 (zh) 2018-08-17
SG11201704887SA (en) 2017-07-28
ECSP17045428A (es) 2018-07-31
SG10201901053TA (en) 2019-03-28
IL286265A (en) 2021-10-31
US20210205437A1 (en) 2021-07-08
CN114057841A (zh) 2022-02-18
MY176597A (en) 2020-08-18
SG10202102695UA (en) 2021-04-29
WO2016100328A1 (en) 2016-06-23
MX371220B (es) 2020-01-08

Similar Documents

Publication Publication Date Title
BR112017012852A2 (pt) novo vírus de tilápia e usos do mesmo
BR112013020070A8 (pt) moléculas de ácido nucleico que codificam novos antígenos de herpes, vacina compreendendo as mesmas e métodos de uso das mesmas
BR112018017307A2 (pt) molécula de ácido nucleico isolada, composição, e, métodos para indução de uma resposta imune contra um zika vírus, para tratamento de um indivíduo e para prevenção de uma infecção por zika vírus
BR112014014078A8 (pt) Composições compreendendo constructos genéticos il-12 aperfeiçoados e vacinas, imunoterapêuticos e métodos de usar os mesmos
AR089797A1 (es) Vacunas contra clostridum difficile que comprenden toxinas recombinantes
BR112017007737A2 (pt) variantes de aav recombinantes e usos das mesmas
EA201790534A1 (ru) Способы и композиции для ослабления иммунных ответов против вирусного вектора для переноса, предназначенного для генной терапии
BR112013012555A2 (pt) peptídeos imunogênicos para o uso na prevenção e/ou no tratamento de doenças infecciosas, doenças autoimunes, respostas imunes a alofatores, doenças alérgicas, tumores, rejeição a enxertos e respostas imunes contra vetores virais usados para a terapia de genes ou na vacinação de genes
BR112019005511A2 (pt) vetores de adenovírus canino
BR112015005987A2 (pt) vacina, métodos para induzir uma resposta imune contra um antígeno hbv, para proteção de um sujeito da infeção por hbv, para proteger o sujeito que foi diagnosticado com uma infecção por hbv, para induzir uma resposta imune contra um antígeno do hbv, para proteger um indivíduo da infecção pelo hbv, para proteger um indivíduo que foi diagnosticado com infecção pelo hbv, para proteger um indivíduo da infecção pelo hbv, para proteger um indivíduo que foi diagnosticado com infecção pelo hbv, para proteger um sujeito contra infecção por hbv e para proteger o sujeito que foi diagnosticado com uma infecção por hbv, molécula de ácido nucleico, e, proteína
AR080313A1 (es) Composiciones de virus de moquillo canino (cdv) recombinante y sus usos
BR112016026651A2 (pt) evolução de vesículas semelhantes a vírus de alta titulação para aplicações de vacina
BR112015022582A2 (pt) molécula de ácido nucleico, plasmídeo, vacina, e, uso de um plasmídeo
NZ739260A (en) Inactivated canine influenza vaccines and methods of making and uses thereof
BR112018008840A2 (pt) anticorpos de domínio único direcionados contra antígenos intracelulares
BR112018014042A2 (pt) vírus do tipo orthomyxo da tilápia.
BR112014020025A2 (pt) vacinas de subunidade de rotavirus e métodos de produção e uso das mesmas
PH12017501100B1 (en) Recombinant swinepox virus and vaccines
BR112016011866A2 (pt) vetores de composições e métodos para induzir uma resposta imune potencializada usando vetores de poxvírus
CY1125328T1 (el) Ανασυνδυασμενο εμβολιο ιου λευχαιμιας αιλουροειδων περιεχοντας βελτιστοποιημενο γονιδιο φακελου ιου λευχαιμιας αιλουροειδων
WO2016022958A3 (en) Tick-associated virus sequences and uses thereof
BR112016017242A2 (pt) Vetores lentivirais para gerar respostas imunes contra o vírus linfotrópico-t humano do tipo 1
AR093530A1 (es) Adyuvante de vacunacion, preparacion, y vacunas que lo contienen
EP4276106A3 (en) Methods and compositions for inducing an immune response using conserved element constructs
MX365656B (es) Nuevas vacunas contra multiples subtipos del virus del dengue.

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09T Decision of refusal: decision cancelled [chapter 9.2.1 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 9.2 NA RPI NO 2764 DE 26/12/2023 POR TER SIDO INDEVIDA.

B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]